Study gut changes in Gulf War illness with chronic stomach symptoms
Part of Digestive system clinical trials.
This study looks at what’s driving Gulf War illness, focusing on gut symptoms like belly pain, diarrhea, and bloating. It may help researchers test approaches aimed at gut barrier function in eligible veterans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a veteran age 18 to 65 who has Gulf War illness
- Have ongoing stomach symptoms (belly pain, diarrhea, or bloating)
- Symptoms began during Persian Gulf deployment
- Have a specific gut “leakiness” test result (lactulose/mannitol ratio above 0.07)
- Be able and willing to follow study instructions and cooperate
- Able to give informed consent and not already be in another research study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether following a study diet can improve symptoms of Gulf War illness. It may help people by confirming whether diet changes are an effective treatment.
This Phase 2 study tests whether resistant potato starch can improve Gulf War illness (GWI), especially gut symptoms and fatigue, in older adults. You may be asked to follow a study plan and provide stool samples, while avoiding certain medications and recent infections.
This Phase 2 study tests whether a calcium–magnesium butyrate supplement can reduce symptoms of Gulf War Illness (GWI), especially by targeting gut and immune-related pathways. You may be eligible if you’re a Gulf War–era veteran with moderate-to-severe physical symptoms and no conditions or medicines that could explain them instead.
This study checks blood tests to see whether they can help confirm Gulf War illness. If you qualify as having Gulf War illness (or are a similar Gulf War veteran without it), your blood and health information may be used to validate these marker tests.
This study closely measures health, thinking, and body function in Gulf War veterans using detailed testing (including exercise testing and possibly brain scans). It aims to better understand what may be driving Gulf War illness and related symptoms, which could improve future care.
This trial studies whether nicotinamide riboside (a vitamin-like substance related to vitamin B3) can improve symptoms of Gulf War illness in eligible Gulf War veterans. If you qualify, you may be asked to take the supplement and complete symptom assessments during the study.
Hear when a new Gulf War Illness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.